HKSE - Delayed Quote HKD

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)

Compare
189.100 -4.000 (-2.07%)
At close: 4:08 PM GMT+8
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
3,509,755.000
993,145.000
812,958.000
Total Liabilities Net Minority Interest
1,180,258.000
4,219,331.000
3,456,844.000
Total Equity Gross Minority Interest
2,329,497.000
-3,226,186.000
-2,643,886.000
Total Capitalization
2,329,497.000
-3,226,186.000
-2,643,886.000
Common Stock Equity
2,329,497.000
-3,226,186.000
-2,643,886.000
Capital Lease Obligations
59,919.000
123,556.000
2,915.000
Net Tangible Assets
2,290,419.000
-3,267,982.000
-2,684,959.000
Working Capital
1,697,483.000
-3,835,045.000
-3,146,573.000
Invested Capital
2,329,497.000
-335,399.000
-255,919.000
Tangible Book Value
2,290,419.000
-3,267,982.000
-2,684,959.000
Total Debt
59,919.000
3,014,343.000
2,390,882.000
Net Debt
--
2,771,566.000
2,269,546.000
Share Issued
219,195.499
215,828.599
215,828.599
Ordinary Shares Number
219,195.499
215,828.599
215,828.599
12/31/2021 - 7/11/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers